# A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

> **NCT02010333** · PHASE2 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 22 (actual)

## Conditions studied

- Head Lice Infestation

## Interventions

- **DRUG:** Ha44 Gel 0.74% w/w

## Key facts

- **NCT ID:** NCT02010333
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-07
- **Final completion:** 2014-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010333, "A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02010333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*